Search Results 41-50 of 12074 for Lupus

  1. A Study to Assess Omega-3 Replacement With Krill Oil in Disease Management of System Lupus Erythematosus (SLE) - Mayo Clinic

    The purpose of this study is to test the hypothesis that subjects with active System Lupus Erythematosus (SLE) will benefit from correcting their omega-3 ...

  2. Mayo Clinic Radio: Awareness Saturday — Arthritis / Osteoporosis / Lupus

    Vaidehi Chowdhary explains the importance of recognizing those who suffer from the chronic inflammatory disease lupus. Listen to the program on Saturday, May 21 ...

  3. Mayo Clinic Radio: Awareness Saturday — Arthritis / Osteoporosis / Lupus

    Mayo Clinic Radio: Awareness Saturday — Arthritis / Osteoporosis / Lupus. By. Jennifer O'Hara. May 16, 2016 ...

  4. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus ...

  5. Doctors and departments - Mayo Clinic

    Mayo Clinic experts are actively researching lupus and testing new treatments for lupus nephritis through the Mayo Nephrology Collaborative Group. As a Mayo ...

  6. Daratumumab to Treat Active Lupus Nephritis - Mayo Clinic

    ... lupus nephritis (LN) as measured by change in proteinuria and serum creatinine. Participation eligibility. Participant eligibility includes age, gender, type ...

  7. A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms - Mayo Clinic

    ... lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms. Participation eligibility. Participant eligibility includes age ...

  8. Belimumab (intravenous route, subcutaneous route) - Mayo Clinic

    Belimumab injection is used to treat active, autoantibody-positive, systemic lupus erythematosus (SLE) and active lupus nephritis in patients who are also ...

  9. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

    Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · Overview · Participation eligibility · Participating Mayo ...

  10. A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

    Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...